On July 12, 2022, at Ho Chi Minh City University of Medicine and Pharmacy Hospital (HCMC UMPH), a signing ceremony of Memorandum of Understanding on cooperation in research and application of stem cell-based treatment took place with the participation of Ho Chi Minh City University of Medicine and Pharmacy Hospital, FBioMed Medical Service Trading Co., Ltd. and Cryoviva Vietnam Tissue Bank.

Press release: Signing ceremony of MOU on research cooperation between Ho Chi Minh City University of Medicine and Pharmacy Hospital and Cryoviva Vietnam Tissue Bank

On July 12, 2022, at Ho Chi Minh City University of Medicine and Pharmacy Hospital (HCMC UMPH), a signing ceremony of Memorandum of Understanding on cooperation in research and application of stem cell-based treatment took place with the participation of Ho Chi Minh City University of Medicine and Pharmacy Hospital, FBioMed Medical Service Trading Co., Ltd. and Cryoviva Vietnam Tissue Bank. This is an event to promote cooperation in the medical field in clinical trial research, application of stem cell-based treatment, technology transfer, medical equipment, training and exchange of medical personnel among units.

Prof. DSc. Dr. Truong Quang Binh – Deputy Director of the hospital shared: “Ho Chi Minh City University of Medicine and Pharmacy Hospital has desired to conduct studies on the application of stem cell-based treatment in therapies for a long time. Therefore, this cooperation will open up many opportunities for in-depth research, promote the potentials and strengths of the parties, bring good results and can be applied for a long time. The hospital hopes that the cooperation between the Hospital, FBioMed Medical Service Trading Co., Ltd. and Cryoviva Vietnam Tissue Bank will be successful.”

Coordination of research and cell biological products – Treatment with umbilical cord derived mesenchymal stem cells

FBioMed Company will coordinate with the Hospital to select a topic and conduct clinical trials applying treatment with umbilical cord derived mesenchymal stem cells. The company will sponsor the entire research and biological costs for Ho Chi Minh City University of Medicine and Pharmacy Hospital for research projects. During the implementation process, stem cells will be stored at Cryoviva Vietnam Tissue Bank – the first independent foreign technology transfer unit licensed by the Ministry of Health to operate in Vietnam.

In Vietnam, stem cells have been researched and applied in the treatment of diseases since the 1990s with the earliest application in the field of hematology – blood transfusion. So far, research and application of stem cell transplantation in disease treatment has developed in many medical facilities to treat a number of diseases such as corneal diseases, cardiomyopathy, skin wounds, diabetes. The therapeutic potential of stem cells is increasingly studied and widely applied.

The process of research cooperation between the parties ensures compliance with the provisions of law, the procedure of the Department of Science, Technology and Training – Ministry of Health, approved by the Hospital’s Scientific Committee and research records are appraised before conducting clinical trials by the Ethics Committee of Ministry of Health.

If positive research results are achieved, when the project is successfully implemented and accepted by the Ministry of Health, the Hospital is entitled to conduct treatment for patients at the hospital according to the protocol. This serves as the premise to promote the continuous cooperation between FBioMed Company, Cryoviva Vietnam Tissue Bank to conduct more extensive research in the application of stem cell-based treatment at Ho Chi Minh City University of Medicine and Pharmacy Hospital in the future.

FBioMed Medical Service Trading Co., Ltd.

FBioMed Medical Service Trading Co., Ltd. specializes in distribution of cell biological products, which is a pioneer in the field of stem cell distribution satisfying AABB (Association for the Advancement of Blood & Biotherapies) standards for research and treatment in Vietnam. FBioMed is a member company of FSCB Service Business Co., Ltd – the authorized representative of Reviva Thailand in Vietnam (under the Cryoviva International Stem Cell Bank system).

Previously, on March 25, 2022, at Hung Vuong Hospital (HCMC.), Hung Vuong Hospital and FBioMed Medical Service Trading Co., Ltd. officially entered into a research cooperation agreement with the topic: “Clinical trial for evaluation of the efficacy and safety of umbilical cord-derived mesenchymal stem cell infusion in patients with thin endometrium during stored embryo transfer process at Hung Vuong Hospital”. The promotion of cooperation with hospitals in research and application of stem cells in treatment is the strategic direction of FBioMed and Cryoviva to bring new hope to patients in need of treatment in Vietnam.

__________________________________________________

Cryoviva Vietnam Stem Cell Bank

Cryoviva Vietnam stem cell bank based on the first foreign technology transfer licensed by the Ministry of Health to operate in Vietnam.

With a team of skilled doctors, nurses and consultants who are always ready to support sampling across 63 provinces and accompanying benefits, including:
✓ The cost of storing stem cells is only with 3,2 million VND/month in 12 months
✓ Free shipping all over Vietnam
✓ 3 times compensation when there is a risk to the stored specimen.

Cryoviva Vietnam specializes in cell culture and storage with the most advanced technology in order to ensure cell quality according to Cleanroom Class 100 & 100,000 standards and coordinate with clinical research hospitals to apply stem cells in treatment.